October 28, 2021
5:00 p.m. CEST | 4:00 p.m. BST | 11:00 a.m. CT | 8:00 a.m. PT
It has been almost two years since the Ion Torrent™ Genexus™ Integrated Sequencer was introduced to the world. We are proud of its reception by the scientific community and the role it has played in enabling laboratories around the world to provide fast genomic profiling services, even in times of crisis.
In this webinar, we’ll introduce two European laboratories, which did not use next generation sequencing (NGS) prior to implementing Ion Torrent™ Genexus™ System.
They will share their experiences, discuss why they decided to implement the Genexus System with the Oncomine™ Precision Assay for research oncology biomarker testing in their laboratories, and how easy it really is In addition, Jon Sherlock, director of oncology product management at Thermo Fisher Scientific, will outline the company’s plans for making these products compliant with IVDR.
Learning Objectives:
- Hear experiences from different laboratories using Ion Torrent Genexus System and Oncomine Precision Assay
- Learn about Thermo Fisher Scientific's plan for IVDR transition in 2022
- Have a chance to ask questions and get answers live concerning both topics
